Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
08.01.26
/
50%
€160.80
Target price
08.01.27
-
Performance (%)
-0.56%
Price
09:53
€159.90
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Biogen Inc. is nearly unchanged. This prediction currently runs until 08.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 2.482% | 2.482% |
| iShares Core DAX® | 1.301% | -1.386% |
| iShares Nasdaq 100 | 0.612% | -4.172% |
| iShares Nikkei 225® | 8.772% | 9.777% |
| iShares S&P 500 | 0.254% | -2.301% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for BIIB provided by MarketBeat